Glomerular filtration function decline, mortality, and cardiovascular events: data from the Strong Heart Study.
Authors:
Journal: Kidney360
Publication Type: Journal Article
Date: 2021
DOI: NIHMS1696466
ID: 33954294
Abstract
Rapid kidney decline is associated with mortality and cardiovascular disease, even in the absence of chronic kidney disease. American Indians (AI) have particularly high burden of kidney disease, cardiovascular disease, and stroke. This study aims to examine extreme loss in glomerular function in this population in association with clinical outcomes.
Reference List
- Hazzard WR, Halter JB: Hazzard’s Geriatric Medicine and Gerontology, New York, McGraw-Hill Medical, 2009|||Kelly KJ, Dominguez JH: Rapid progression of diabetic nephropathy is linked to inflammation and episodes of acute renal failure. Am J Nephrol 32: 469–475, 2010. 10.1159/000320749|||Weng SC, Tarng DC, Chen CM, Cheng CH, Wu MJ, Chen CH, Yu TM, Shu KH; CKDBHPDH investigators: Estimated glomerular filtration rate decline is a better risk factor for outcomes of systemic disease-related nephropathy than for outcomes of primary renal diseases. PLoS One 9: e92881, 2014. 10.1371/journal.pone.0092881|||Eftimovska N, Stojceva-Taneva O, Polenakovic M: Slow progression of chronic kidney disease and what it is associated with. Prilozi 29: 153–165, 2008|||Looker HC, Colombo M, Hess S, Brosnan MJ, Farran B, Dalton RN, Wong MC, Turner C, Palmer CN, Nogoceke E, Groop L, Salomaa V, Dunger DB, Agakov F, McKeigue PM, Colhoun HM; SUMMIT Investigators: Biomarkers of rapid chronic kidney disease progression in type 2 diabetes. Kidney Int 88: 888–896, 2015. 10.1038/ki.2015.199|||Warady BA, Abraham AG, Schwartz GJ, Wong CS, Muñoz A, Betoko A, Mitsnefes M, Kaskel F, Greenbaum LA, Mak RH, Flynn J, Moxey-Mims MM, Furth S: Predictors of rapid progression of glomerular and nonglomerular kidney disease in children and adolescents: The Chronic Kidney Disease in Children (CKiD) cohort. Am J Kidney Dis 65: 878–888, 2015. 10.1053/j.ajkd.2015.01.008|||Al-Aly Z, Zeringue A, Fu J, Rauchman MI, McDonald JR, El-Achkar TM, Balasubramanian S, Nurutdinova D, Xian H, Stroupe K, Abbott KC, Eisen S: Rate of kidney function decline associates with mortality. J Am Soc Nephrol 21: 1961–1969, 2010. 10.1681/ASN.2009121210|||Naimark DM, Grams ME, Matsushita K, Black C, Drion I, Fox CS, Inker LA, Ishani A, Jee SH, Kitamura A, Lea JP, Nally J, Peralta CA, Rothenbacher D, Ryu S, Tonelli M, Yatsuya H, Coresh J, Gansevoort RT, Warnock DG, Woodward M, de Jong PE; CKD Prognosis Consortium: Past decline versus current eGFR and subsequent mortality risk. J Am Soc Nephrol 27: 2456–2466, 2016. 10.1681/ASN.2015060688|||Perkins RM, Tang X, Bengier AC, Kirchner HL, Bucaloiu ID: Variability in estimated glomerular filtration rate is an independent risk factor for death among patients with stage 3 chronic kidney disease. Kidney Int 82: 1332–1338, 2012. 10.1038/ki.2012.281|||Derose SF, Rutkowski MP, Crooks PW, Shi JM, Wang JQ, Kalantar-Zadeh K, Kovesdy CP, Levin NW, Jacobsen SJ: Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system. Am J Kidney Dis 62: 236–244, 2013. 10.1053/j.ajkd.2013.01.019|||Matsushita K, Selvin E, Bash LD, Franceschini N, Astor BC, Coresh J: Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol 20: 2617–2624, 2009. 10.1681/ASN.2009010025|||Zhang Y, Lee ET, Howard BV, Best LG, Umans JG, Yeh J, Wang W, Yeh F, Ali T, Devereux RB, de Simone G: Insulin resistance, incident cardiovascular diseases, and decreased kidney function among nondiabetic American Indians: The Strong heart study. Diabetes Care 36: 3195–3200, 2013. 10.2337/dc12-2368|||O’Connell J, Yi R, Wilson C, Manson SM, Acton KJ: Racial disparities in health status: A comparison of the morbidity among American Indian and U.S. adults with diabetes. Diabetes Care 33: 1463–1470, 2010. 10.2337/dc09-1652|||Makin SDJ, Cook FAB, Dennis MS, Wardlaw JM: Cerebral small vessel disease and renal function: Systematic review and meta-analysis. Cerebrovasc Dis 39: 39–52, 2015. 10.1159/000369777|||Luo S, Qi RF, Wen JQ, Zhong JH, Kong X, Liang X, Xu Q, Zheng G, Zhang Z, Zhang LJ, Lu GM: Abnormal intrinsic brain activity patterns in patients with end-stage renal disease undergoing peritoneal dialysis: A resting-state functional MR imaging study. Radiology 278: 181–189, 2016. 10.1148/radiol.2015141913|||Kobayashi M, Hirawa N, Yatsu K, Kobayashi Y, Yamamoto Y, Saka S, Andoh D, Toya Y, Yasuda G, Umemura S: Relationship between silent brain infarction and chronic kidney disease. Nephrol Dial Transplant 24: 201–207, 2009. 10.1093/ndt/gfn419|||Akoudad S, Sedaghat S, Hofman A, Koudstaal PJ, van der Lugt A, Ikram MA, Vernooij MW: Kidney function and cerebral small vessel disease in the general population. Int J Stroke 10: 603–608, 2015. 10.1111/ijs.12465|||Martinez-Vea A, Salvadó E, Bardají A, Gutierrez C, Ramos A, García C, Compte T, Peralta C, Broch M, Pastor R, Angelet P, Marcas L, Saurí A, Oliver JA: Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD. Am J Kidney Dis 47: 241–250, 2006. 10.1053/j.ajkd.2005.10.029|||Nagai M, Hoshide S, Takahashi M, Shimpo M, Kario K: Sleep duration, kidney function, and their effects on cerebral small vessel disease in elderly hypertensive patients. Am J Hypertens 28: 884–893, 2015. 10.1093/ajh/hpu243|||Sedaghat S, Vernooij MW, Loehrer E, Mattace-Raso FU, Hofman A, van der Lugt A, Franco OH, Dehghan A, Ikram MA: Kidney function and cerebral blood flow: The rotterdam study. J Am Soc Nephrol 27: 715–721, 2016. 10.1681/ASN.2014111118|||Vogels SC, Emmelot-Vonk MH, Verhaar HJ, Koek HL: The association of chronic kidney disease with brain lesions on MRI or CT: A systematic review. Maturitas 71: 331–336, 2012. 10.1016/j.maturitas.2012.01.008|||Stansbury JP, Jia H, Williams LS, Vogel WB, Duncan PW: Ethnic disparities in stroke: Epidemiology, acute care, and postacute outcomes. Stroke 36: 374–386, 2005. 10.1161/01.STR.0000153065.39325.fd|||Harwell TS, Oser CS, Okon NJ, Fogle CC, Helgerson SD, Gohdes D: Defining disparities in cardiovascular disease for American Indians: Trends in heart disease and stroke mortality among American Indians and whites in Montana, 1991 to 2000. Circulation 112: 2263–2267, 2005. 10.1161/CIRCULATIONAHA.105.560607|||Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P; American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics-2017 update: A report from the American Heart Association [published correction appears in Circulation 135: e646, 2017 10.1161/CIR.0000000000000491]. Circulation 135: e146–e603, 2017. 10.1161/CIR.0000000000000485|||Lee ET, Welty TK, Fabsitz R, Cowan LD, Le NA, Oopik AJ, Cucchiara AJ, Savage PJ, Howard BV: The Strong Heart Study. A study of cardiovascular disease in American Indians: Design and methods. Am J Epidemiol 132: 1141–1155, 1990. 10.1093/oxfordjournals.aje.a115757|||Shara NM, Wang H, Mete M, Al-Balha YR, Azalddin N, Lee ET, Franceschini N, Jolly SE, Howard BV, Umans JG: Estimated GFR and incident cardiovascular disease events in American Indians: The Strong Heart Study. Am J Kidney Dis 60: 795–803, 2012. 10.1053/j.ajkd.2012.06.015|||Zhang Y, Galloway JM, Welty TK, Wiebers DO, Whisnant JP, Devereux RB, Kizer JR, Howard BV, Cowan LD, Yeh J, Howard WJ, Wang W, Best L, Lee ET: Incidence and risk factors for stroke in American Indians: The Strong Heart Study. Circulation 118: 1577–1584, 2008. 10.1161/CIRCULATIONAHA.108.772285|||Mancia G: Visit-to-visit blood pressure variability: An insight into the mechanisms. Hypertension 68: 32–33, 2016. 10.1161/HYPERTENSIONAHA.116.07139|||Muntner P, Levitan EB: Visit-to-visit variability of blood pressure: Current knowledge and future research directions. Blood Press Monit 18: 232–238, 2013. 10.1097/MBP.0b013e3283624b24|||Suchy-Dicey AM, Wallace ER, Mitchell SV, Aguilar M, Gottesman RF, Rice K, Kronmal R, Psaty BM, Longstreth WT Jr: Blood pressure variability and the risk of all-cause mortality, incident myocardial infarction, and incident stroke in the cardiovascular health study. Am J Hypertens 26: 1210–1217, 2013. 10.1093/ajh/hpt092|||Chang TI, Tabada GH, Yang J, Tan TC, Go AS: Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease. J Hypertens 34: 244–252, 2016. 10.1097/HJH.0000000000000779|||Hsieh YT, Tu ST, Cho TJ, Chang SJ, Chen JF, Hsieh MC: Visit-to-visit variability in blood pressure strongly predicts all-cause mortality in patients with type 2 diabetes: A 5·5-year prospective analysis. Eur J Clin Invest 42: 245–253, 2012. 10.1111/j.1365-2362.2011.02574.x|||Lau KK, Wong YK, Chang RS, Teo KC, Hon SF, Chan KH, Wat KL, Cheung RT, Li LS, Siu CW, Ho SL, Tse HF: Visit-to-visit systolic blood pressure variability predicts all-cause and cardiovascular mortality after lacunar infarct. Eur J Neurol 21: 319–325, 2014. 10.1111/ene.12310|||Hussein WF, Chang TI: Visit-to-visit variability of systolic blood pressure and cardiovascular disease. Curr Hypertens Rep 17: 14, 2015. 10.1007/s11906-014-0527-8|||Mallamaci F, Minutolo R, Leonardis D, D’Arrigo G, Tripepi G, Rapisarda F, Cicchetti T, Maimone I, Enia G, Postorino M, Santoro D, Fuiano G, De Nicola L, Conte G, Zoccali C: Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. Kidney Int 84: 381–389, 2013. 10.1038/ki.2013.132|||Nagai M, Kario K: Visit-to-visit blood pressure variability, silent cerebral injury, and risk of stroke. Am J Hypertens 26: 1369–1376, 2013. 10.1093/ajh/hpt167|||Okada R, Okada A, Okada T, Nanasato M, Wakai K: Visit-to-visit blood pressure variability is a marker of cardiac diastolic function and carotid atherosclerosis. BMC Cardiovasc Disord 14: 188, 2014. 10.1186/1471-2261-14-188|||Rossignol P, Kessler M, Zannad F: Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseases. Curr Opin Nephrol Hypertens 22: 59–64, 2013. 10.1097/MNH.0b013e32835b489f|||Song H, Wei F, Liu Z, Zhao Y, Ye L, Lu F, Zhang H, Diao Y, Qi Z, Xu J: Visit-to-visit variability in systolic blood pressure: Correlated with the changes of arterial stiffness and myocardial perfusion in on-treated hypertensive patients. Clin Exp Hypertens 37: 63–69, 2015. 10.3109/10641963.2014.897724|||Lattanzi S, Viticchi G, Falsetti L, Buratti L, Luzzi S, Provinciali L, Silvestrini M: Visit-to-visit blood pressure variability in Alzheimer disease. Alzheimer Dis Assoc Disord 28: 347–351, 2014. 10.1097/WAD.0000000000000040|||Ogliari G, Smit RA, Westendorp RG, Jukema JW, de Craen AJ, Sabayan B: Visit-to-visit blood pressure variability and future functional decline in old age. J Hypertens 34: 1544–1550, 2016. 10.1097/HJH.0000000000000979|||Sabayan B, Wijsman LW, Foster-Dingley JC, Stott DJ, Ford I, Buckley BM, Sattar N, Jukema JW, van Osch MJ, van der Grond J, van Buchem MA, Westendorp RG, de Craen AJ, Mooijaart SP: Association of visit-to-visit variability in blood pressure with cognitive function in old age: Prospective cohort study. BMJ 347: f4600, 2013. 10.1136/bmj.f4600